当前位置:首页 - 行情中心 - 贝达药业(300558) - 财务分析

贝达药业

(300558)

  

流通市值:208.56亿  总市值:209.24亿
流通股本:4.17亿   总股本:4.18亿

贝达药业(300558)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.95亿元,每股收益0.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益563129.96万元,未分配利润272473.67万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产912551.83万元,负债349421.87万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入917,554,506.922,891,950,112.032,344,643,009.241,500,765,619.93
营业总成本730,520,724.152,460,400,758.661,978,236,019.161,261,367,094.02
营业利润123,067,237.11399,871,684.57438,271,814.06253,891,097.59
利润总额123,152,668.55394,158,101.64431,823,507.59250,082,716.09
净利润95,463,516.48386,979,402.58405,153,844.02216,123,850.75
其他综合收益-137,880,994.1556,915,948.89-32,146,129.6114,552,762.64
综合收益总额-42,417,477.67443,895,351.47373,007,714.41230,676,613.39
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,301,717,893.561,224,330,599.971,526,566,689.451,184,580,501.76
非流动资产合计7,823,800,408.48,117,347,123.847,831,405,379.987,957,303,939.68
资产总计9,125,518,301.969,341,677,723.819,357,972,069.439,141,884,441.44
流动负债合计2,092,412,147.121,847,959,887.481,776,897,468.141,691,250,986.52
非流动负债合计1,401,806,555.711,827,607,601.771,854,963,323.221,886,496,244.89
负债合计3,494,218,702.833,675,567,489.253,631,860,791.363,577,747,231.41
归属于母公司股东权益合计5,543,677,139.015,573,806,060.135,636,950,298.895,471,675,324.94
股东权益合计5,631,299,599.135,666,110,234.565,726,111,278.075,564,137,210.03
负债和股东权益合计9,125,518,301.969,341,677,723.819,357,972,069.439,141,884,441.44
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计968,760,882.263,219,792,5912,548,182,394.11,663,805,651.24
经营活动现金流出小计671,225,194.252,308,620,414.781,716,841,655.311,142,113,321.65
经营活动产生的现金流量净额297,535,688.01911,172,176.22831,340,738.79521,692,329.59
投资活动现金流入小计100,00031,722,710.162,050,815.97140,367
投资活动现金流出小计192,857,786.751,033,415,672.65783,733,321.62640,864,277.77
投资活动产生的现金流量净额-192,757,786.75-1,001,692,962.49-781,682,505.65-640,723,910.77
筹资活动现金流入小计150,000,000644,750,000483,600,000408,600,000
筹资活动现金流出小计178,190,846.43836,133,783.9683,894,076.8575,676,906.49
筹资活动产生的现金流量净额-28,190,846.43-191,383,783.9-200,294,076.8-167,076,906.49
汇率变动对现金及现金等价物的影响-133,207.851,590,510.79-6,019,687.56-983,640.38
现金及现金等价物净增加额76,453,846.98-280,314,059.38-156,655,531.22-287,092,128.05
期末现金及现金等价物余额548,136,702.1471,682,855.12595,341,383.28464,904,786.45
最新报告期:2025-04-26
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中金公司张琎,刘雅馨,朱言音1.732.19--2025-04-26
浙商证券郭双喜1.712.423.072025-04-25
长城国瑞证券胡晨曦,魏钰琪1.281.441.772025-04-23
华创证券刘浩1.181.652.262025-04-23
华安证券谭国超1.462.162.882025-04-21
TOP↑